- Previous Close
659.95 - Open
654.25 - Bid 648.10 x --
- Ask 647.25 x --
- Day's Range
640.25 - 660.45 - 52 Week Range
406.35 - 744.00 - Volume
40,821 - Avg. Volume
42,195 - Market Cap (intraday)
490.081B - Beta (5Y Monthly) 0.56
- PE Ratio (TTM)
63.89 - EPS (TTM)
10.16 - Earnings Date May 21, 2025 - May 26, 2025
- Forward Dividend & Yield 1.00 (0.15%)
- Ex-Dividend Date Jul 24, 2024
- 1y Target Est
736.53
Fortis Healthcare Limited, an integrated healthcare delivery service provider, offers secondary, tertiary, and quaternary care in India. The company offers services in the areas of cardiac science, cosmetology, dental science, dermatology, diabetology/endocrinology, emergency and trauma, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, haematology, infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surgery, neurointerventional radiology, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy and rehabilitation, plastic and reconstructive surgery, pulmonology, radiology, organ transplanrheumatology, thoracic surgery, transplantation medicine, urology, and other support specialties, as well as ear, nose, and throat. Its healthcare verticals comprise hospitals, diagnostics, and day care specialty facilities. Fortis Healthcare Limited was founded in 1995 and is based in Gurugram, India.
www.fortishealthcare.com12,088
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: FORTIS.BO
View MorePerformance Overview: FORTIS.BO
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FORTIS.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FORTIS.BO
View MoreValuation Measures
Market Cap
498.23B
Enterprise Value
503.78B
Trailing P/E
64.83
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.64
Price/Book (mrq)
6.35
Enterprise Value/Revenue
6.71
Enterprise Value/EBITDA
32.58
Financial Highlights
Profitability and Income Statement
Profit Margin
10.17%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
75.61B
Net Income Avi to Common (ttm)
7.69B
Diluted EPS (ttm)
10.16
Balance Sheet and Cash Flow
Total Cash (mrq)
6.01B
Total Debt/Equity (mrq)
13.59%
Levered Free Cash Flow (ttm)
--